Page last updated: 2024-12-05

methyleugenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Methyleugenol is a naturally occurring phenylpropanoid compound found in various plants, including nutmeg, cinnamon, and basil. It is a colorless liquid with a characteristic spicy, clove-like aroma. Methyleugenol is known for its potent biological activities, including antimicrobial, antifungal, and anti-inflammatory properties. It has been studied for its potential use in traditional medicine and as a flavoring agent in food and beverages. Its synthesis involves the methylation of eugenol, another phenylpropanoid compound. Methyleugenol's effects can vary depending on the dosage and mode of administration. It has been shown to have both beneficial and adverse effects, with high doses associated with potential toxicity. Research into methyleugenol focuses on understanding its pharmacological properties, exploring its potential applications in medicine and agriculture, and assessing its safety and efficacy.'

methyleugenol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7127
CHEMBL ID108861
CHEBI ID4918
SCHEMBL ID113794
SCHEMBL ID10108224
MeSH IDM0046616

Synonyms (115)

Synonym
AKOS015838877
benzene, 1,2-dimethoxy-4-(2-propenyl)-
benzene, 4-allyl-1,2-dimethoxy-
caswell no. 579ab
1,2-dimethoxy-4-(2-propen-1-yl)benzene
o-methyl eugenol ether
hsdb 4504
fema number 2475
methyl eugenyl ether
epa pesticide chemical code 203900
fema no. 2475
nsc 209528
brn 1910871
ai3-21040
ccris 746
o-methyl eugenol
einecs 202-223-0
1,3,4-eugenol methyl ether
4-allyl-1,2-dimethoxy-benzene
nsc8900
eugenyl methyl ether
1,2-dimethoxy-4-allylbenzene
4-allylveratrole
methyl eugenol ether
3,4-dimethoxyallylbenzene
1-(3,4-dimethoxyphenyl)-2-propene
nsc-8900
benzene,2-dimethoxy-4-(2-propenyl)-
1,4-eugenol methyl ether
ent 21040
1,2-dimethoxy-4-(2-propenyl)benzene
wln: 1u2r co1 do1
veratrole methyl ether
1-allyl-3,4-dimethoxybenzene
4-allyl-1,2-dimethoxybenzene
methyl eugenol ,
1,2-dimethoxy-4-(prop-2-en-1-yl)benzene
CHEBI:4918 ,
nsc209528
nsc-209528
NCGC00091474-01
smr000112378
MLS001065600
93-15-2
eugenol methyl ether
methyleugenol
o-methyleugenol
methyl eugenol, >=98%, fcc
4-allyl-1,2-dimethoxybenzene, 99%
NCGC00091474-02
MLS001333206
MLS001333205
1,2-dimethoxy-4-prop-2-enylbenzene
CHEMBL108861
D1360
STK801819
NCGC00091474-03
NCGC00091474-04
benzene, 1,2-dimethoxy-4-(2-propen-1-yl)-
29t9va6r7m ,
ec 202-223-0
unii-29t9va6r7m
dtxsid5025607 ,
cas-93-15-2
tox21_300071
dtxcid505607
NCGC00254085-01
NCGC00259896-01
tox21_202347
HMS2269M09
bdbm50379791
FT-0626371
methyleugenol (constituent of holy basil leaf) [dsc]
methyl eugenol [inci]
veratrole, 4-allyl-
methyleugenol [mi]
methylchavibetol
eugenyl methyl ether [fhfi]
ent-21040
methyl eugenol [fcc]
chavibetol methyl ether
methyleugenol [iarc]
methyleugenol [hsdb]
allylveratrol
SCHEMBL113794
BBL027720
SCHEMBL10108224
1,2-dimethoxy-4-allyl benzene
eugenol methyl
4-allyl-1,2-dimethyoxybenzene
benzene, 4-(2-propenyl)-1,2-dimethoxy
W-100251
AC-34351
3-(3,4-dimethoxyphenyl)-1-propene
mfcd00008652
methyl eugenol, analytical standard
eugenol-methyl ether
1, 2-dimethoxy-4-(2-propenyl)benzene
1-(3, 4-dimethoxyphenyl)-2-propene
4-allyl-1, 2-dimethoxybenzene
fema 2475
allyl-1,2-dimethoxybenzene
Q419829
methyleugenol,(s)
AS-14807
HMS3886M22
trideuteromethyl eugenol
CS-W017325
S5755
HY-N6996
E80630
EN300-698375
Z1255398904
dimethoxy-4-(prop-2-en-1-yl)benzene
methyl ester eugenol

Research Excerpts

Overview

Methyleugenol (ME) is a rodent hepatocarcinogen occurring in many herbs and spices as well as essential oils used for flavoring. ME has multiple biological effects including anticonvulsant and anesthetic activities, although the underlying mechanisms remain unclear.

ExcerptReferenceRelevance
"Methyleugenol (ME) is a ubiquitous component in spices and other culinary herbal products. "(
Feng, Y; Li, W; Peng, Y; Wang, DO; Wang, H; Yang, X; Zhang, Z; Zheng, J, 2020
)
2
"Methyleugenol is a rodent hepatocarcinogen occurring in many herbs and spices as well as essential oils used for flavoring. "( Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels.
Engst, W; Glatt, H; Herrmann, K; Klein, K; Meinl, W; Tremmel, R; Zanger, UM, 2017
)
3.34
"Methyleugenol (ME) is a natural constituent isolated from many plant essential oils having multiple biological effects including anticonvulsant and anesthetic activities, although the underlying mechanisms remain unclear. "( Electrophysiological characterization of methyleugenol: a novel agonist of GABA(A) receptors.
Deng, S; Ding, J; Ge, WH; Huang, C; Li, F; Li, WG; Nie, YZ; Peng, Z; Xie, Y; Xu, TL, 2014
)
2.11
"Methyleugenol (ME) is a natural compound with antiallergic, antianaphylactic, antinociceptive, and anti-inflammatory effects."( Inhibitory effect of methyleugenol on IgE-mediated allergic inflammation in RBL-2H3 cells.
Chen, F; Huang, Y; Ling, X; Tan, X; Tang, F; Tang, Q; Zheng, X, 2015
)
1.46
"Methyleugenol is a substituted alkenylbenzene found in several herbs and spices. "( Methyleugenol and oxidative metabolites induce DNA damage and interact with human topoisomerases.
Esselen, M; Groh, IA; Gründken, M; Marko, D; Rudakovski, O; Schroeter, A, 2016
)
3.32
"Methyleugenol is a substituted alkenylbenzene classified by the European Union's Scientific Committee on Food as a genotoxic carcinogen. "( Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells.
Cartus, AT; Esselen, M; Groh, IA; Kajzar, J; Merz, KH; Schrenk, D; Vallicotti, S, 2012
)
2.13
"Methyleugenol (1) is a constituent of many foods, in particular of herbal spices, and is used as flavoring agent in foodstuffs and as fragrance in cosmetics. "( Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Cartus, AT; Engst, W; Glatt, H; Herrmann, K; Merz, KH; Schrenk, D; Weishaupt, LW, 2012
)
2.18
"Methyleugenol is a genotoxic carcinogen in mice and rats, the liver being the primary target tissue. "( Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human liver samples.
Appel, KE; Engst, W; Glatt, H; Herrmann, K; Klein, K; Schumacher, F; Zanger, UM, 2013
)
2.13
"Methyleugenol was found to be a very potent multisite carcinogen in male and female F344/N rats and B6C3F1 mice at all doses tested in 2-year NTP bioassays using gavage dosing."( Human consumption of methyleugenol and its elimination from serum.
Abdo, KM; Barr, DB; Barr, JR; Blumenthal, G; Cunningham, ML; Lucier, GW; Masten, S; Melnick, R; Mignogna, J; Needham, LL; Patterson, DG; Portier, C; Schecter, A; Silver, AG; Stanfill, SB; Stopford, W; Tung, KC, 2004
)
1.36
"Methyleugenol is an allylbenzene food flavoring which has been shown to form DNA and protein adducts, and to cause hepatotoxicity and carcinogenicity in rodents. "( Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
Bergin, P; Caldwell, J; Gardner, I; Kenna, JG; Stening, P, 1996
)
1.96
"Methyleugenol (ME) is a natural constituent of the essential oils of a number of plants widely used in foodstuffs as flavouring agents. "( Constituents of aromatic plants: I. Methyleugenol.
De Vincenzi , M; Scazzocchio, B; Silano, M; Stacchini, P, 2000
)
2.02
"Methyleugenol is a substituted alkenylbenzene found in a variety of foods, products, and essential oils. "( Cytotoxicity and genotoxicity of methyleugenol and related congeners-- a mechanism of activation for methyleugenol.
Burkey, JL; McQueen, CA; Sauer, JM; Sipes, IG, 2000
)
2.03

Effects

ExcerptReferenceRelevance
"1. Methyleugenol (MEG) has been used as a flavouring agent in food, as a fragrance in cosmetic products, and as an insect attractant. "( Toxicokinetics of methyleugenol in F344 rats and B6C3F₁ mice.
Bates, DJ; Fuciarelli, AF; Graves, SW; Hong, SP; Johnson, JD; Smith, CS; Waidyanatha, S, 2013
)
1.35

Toxicity

ExcerptReferenceRelevance
" Additionally, methyleugenol induced hypoproteinemia and hypoalbuminemia, evidenced by decreased total protein and albumin concentrations in both male and female rats, suggesting in inefficiency of dietary protein utilization due to methyleugenol-induced toxic effects on the liver and glandular stomach of rats and mice."( 14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice.
Abdo, KM; Bucher, JR; Cunningham, ML; Eldridge, SR; Herbert, RA; Snell, ML; Travlos, GS, 2001
)
0.93

Compound-Compound Interactions

ExcerptReferenceRelevance
" Carvacrol was the most active phenol with median MIC of 125 µg/ml and its combination with fluconazole, amphotericin B, nystatin and caspofungin resulted synergistic and additive effects in 68%, 64%, 96% and 28%, respectively."( Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris.
Ahmad, A; Patel, M; Shaban, S, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
" Absolute bioavailability following gavage administration of 37 mg/kg was low in both rats (~4%) and mice (7-9%) of both sexes indicating extensive first-pass metabolism."( Toxicokinetics of methyleugenol in F344 rats and B6C3F₁ mice.
Bates, DJ; Fuciarelli, AF; Graves, SW; Hong, SP; Johnson, JD; Smith, CS; Waidyanatha, S, 2013
)
0.72

Dosage Studied

ExcerptRelevanceReference
" The non-linear dose-response curves for genotoxicity obtained with the allylbenzenes and their 1'-hydroxy metabolites indicate that it is important to consider dose-dependence in metabolism when interpreting the significance to humans of animal data obtained with very high doses of the compounds studied."( Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Caldwell, J; Chan, VS, 1992
)
0.28
" Additional groups of rats and mice of each sex were dosed similarly and used for hematology and clinical chemistry studies."( 14-Week toxicity and cell proliferation of methyleugenol administered by gavage to F344 rats and B6C3F1 mice.
Abdo, KM; Bucher, JR; Cunningham, ML; Eldridge, SR; Herbert, RA; Snell, ML; Travlos, GS, 2001
)
0.57
" Nevertheless, further studies are needed to define both the nature and implications of the dose-response curve in rats at low levels of exposure to methyl eugenol and estragole."( Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole.
Adams, TB; Caldwell, J; Doull, J; Feron, VJ; Goodman, JI; Marnett, LJ; Portoghese, PS; Rogers, AE; Sipes, IG; Smith, RL; Waddell, WJ; Wagner, BM, 2002
)
0.31
"Comparisons on a linear and the Rozman logarithmic scale for dosage versus carcinogenicity in rodents are presented for methyl eugenol (ME), nitrosodiethylamine (NDEA), ethyl carbamate (EC) and 2-acetylaminofluorene (AAF)."( Comparisons of thresholds for carcinogenicity on linear and logarithmic dosage scales.
Waddell, WJ, 2005
)
0.33
" All test chemicals acted fast and showed a steep dose-response relationship."( Insecticidal activity of basil oil, trans-anethole, estragole, and linalool to adult fruit flies of Ceratitis capitata, Bactrocera dorsalis, and Bactrocera cucurbitae.
Chang, CL; Cho, IK; Li, QX, 2009
)
0.35
" These results suggest that tumor formation could be lower in rodent bioassays when methyleugenol would be dosed in a matrix containing SULT inhibitors such as nevadensin compared to experiments using the pure methyleugenol."( The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
Adams, TB; Alhusainy, W; Iatropoulos, MJ; Jeffrey, AM; Rietjens, IM; Taylor, S; Williams, GM, 2014
)
0.87
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
phenylpropanoidAny organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Olfactory Signaling Pathway8028
volatile cinnamoic ester biosynthesis016
Sensory Perception21568
volatile cinnamoic ester biosynthesis216

Protein Targets (22)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency8.15480.044717.8581100.0000AID485294; AID485341
LuciferasePhotinus pyralis (common eastern firefly)Potency63.98410.007215.758889.3584AID1224835
ATAD5 protein, partialHomo sapiens (human)Potency25.91850.004110.890331.5287AID504467
GLI family zinc finger 3Homo sapiens (human)Potency0.24580.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency0.03980.000221.22318,912.5098AID588516
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency31.62280.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency24.58420.000657.913322,387.1992AID1259377
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency25.11890.000214.376460.0339AID588532
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency12.19720.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency7.76060.000817.505159.3239AID1159527
farnesoid X nuclear receptorHomo sapiens (human)Potency0.01260.375827.485161.6524AID588527
estrogen nuclear receptor alphaHomo sapiens (human)Potency42.19350.000229.305416,493.5996AID743075; AID743077; AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency7.76060.023723.228263.5986AID743223
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency1.58490.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency33.49150.000627.21521,122.0200AID651741
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency39.81070.251215.843239.8107AID504327
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)IC50 (µMol)33.30000.07002.12673.5000AID1801921
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)EC50 (µMol)40.00000.00000.992210.0000AID655422
Peroxisome proliferator-activated receptor deltaHomo sapiens (human)EC50 (µMol)50.60000.00020.84609.1000AID652614
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)EC50 (µMol)46.50000.00061.607410.0000AID655421
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (135)

Processvia Protein(s)Taxonomy
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of cholesterol effluxPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
long-chain fatty acid transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of osteoblast differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of receptor signaling pathway via STATPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of low-density lipoprotein receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of MAP kinase activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adiponectin secretionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cardiac muscle hypertrophy in response to stressPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of connective tissue replacement involved in inflammatory response wound healingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
placenta developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
G protein-coupled receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of blood pressurePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of gene expressionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of lipid storagePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of angiogenesisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
monocyte differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
BMP signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
epithelial cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
response to lipidPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
glucose homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
mRNA transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipoprotein transportPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
innate immune responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell fate commitmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
retinoic acid receptor signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell maturationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
rhythmic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
white fat cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
lipid homeostasisPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of SMAD protein signal transductionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cholesterol transporter activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to low-density lipoprotein particle stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of mitochondrial fissionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
regulation of cellular response to insulin stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of extracellular matrix assemblyPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of miRNA transcriptionPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of cellular response to transforming growth factor beta stimulusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of adipose tissue developmentPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular associated smooth muscle cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of vascular endothelial cell proliferationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
generation of precursor metabolites and energyPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid beta-oxidationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
embryo implantationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cholesterol metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell population proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
axon ensheathmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid catabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of gene expressionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
regulation of skeletal muscle satellite cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell-substrate adhesionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to nutrient levelsPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of skeletal muscle tissue regenerationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of myoblast differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
decidualizationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of epithelial cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
keratinocyte migrationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
adipose tissue developmentPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fat cell proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cellular response to hypoxiaPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
energy homeostasisPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
apoptotic signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
glucose transmembrane transportPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of myoblast proliferationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor deltaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (42)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
transcription coregulator bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
double-stranded DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
prostaglandin receptor activityPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
enzyme bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
peptide bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
identical protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nuclear retinoid X receptor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
arachidonic acid bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA binding domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
LBD domain bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
alpha-actinin bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
R-SMAD bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
E-box bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
STAT family protein bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
linoleic acid bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
sequence-specific double-stranded DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
cytosolPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
intracellular membrane-bounded organellePeroxisome proliferator-activated receptor gammaHomo sapiens (human)
RNA polymerase II transcription regulator complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
receptor complexPeroxisome proliferator-activated receptor gammaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor deltaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (84)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1102081Acaricidal activity against Dermatophagoides farinae assessed as mortality at 1.2 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID376048Antifungal activity against Epidermophyton floccosum C 114 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1104348Feeding deterrent activity against freshly molted third-instar larval stage of Trichoplusia ni (cabbage looper) in compound pretreated cabbage leaves at 50 ug/cm2 after 3 to 5 hr by leaf disk choice bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID376055Antifungal activity against Microsporum canis C 112 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID334999Antimicrobial activity against Pityrosporum ovale ATCC 14521 by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID376044Antifungal activity against Epidermophyton floccosum C 114 up to 50 ug/mL by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID334997Antimicrobial activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334994Antimicrobial activity against Escherichia coli ATCC 9637 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1102057Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 0.8 to 1.2 ug/cm2 after 24 to 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID376045Antifungal activity against Microsporum gypseum C 115 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID376047Antifungal activity against Trichophyton rubrum C 113 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID376054Antifungal activity against Aspergillus niger ATCC 9029 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1102080Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.8 ug/cm2 after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1501101Induction of NO generation in Leishmania donovani MHOM/IN/AG/83 infected BALB/c mouse peritoneal macrophages assessed as nitrite levels after 48 hrs by Griess assay relative to untreated control2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID376043Antifungal activity against Trichophyton rubrum C 113 up to 50 ug/mL by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1501099Therapeutic index, ratio of IC50 for mouse RAW264.7 cells to IC50 for Leishmania donovani MHOM/IN/AG/83 promastigotes2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID166551Percentage inhibition against release of beta-hexosaminidase from RBL-2H3 cells at 100 uM from control2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells.
AID334992Antimicrobial activity against Staphylococcus aureus ATCC 12598 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1102089Acaricidal activity against Dermatophagoides farinae after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID376040Antifungal activity against Microsporum canis C 112 up to 50 ug/mL by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1102086Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides pteronyssinus2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID335000Antimicrobial activity against Penicillium chrysogenum ATCC 10106 after 5 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1439501Nematocidal activity against Meloidogyne incognita2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1102053Acaricidal activity against Dermatophagoides farinae assessed as mortality at 25.5 ug/cm2 applied as fumes in open container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID655421Transactivation of GAL4-fused PPARalpha LBD expressed in HepG2 cells after 20 hrs by luminescence assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID1102054Acaricidal activity against Dermatophagoides farinae assessed as mortality at 25.5 ug/cm2 applied as fumes in closed container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1501097Cytotoxicity against mouse RAW264.7 cells after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID334996Antimicrobial activity against Enterobacter aerogenes ATCC 13048 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID376046Antifungal activity against Trichophyton mentagrophytes ATCC by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID376052Antifungal activity against Aspergillus flavus ATCC 9170 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1102051Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 25.5 ug/cm2 applied as fumes in open container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID337837Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID334989Antimicrobial activity against Bacillus subtilis ATCC 9372 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1102063Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.8 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID395274Inhibition of 15-lipoxygenase form soybean2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them.
AID1501100Therapeutic index, ratio of EC50 for BALB/c mouse peritoneal macrophages to EC50 for Leishmania donovani MHOM/IN/AG/83 amastigotes2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID376041Antifungal activity against Microsporum gypseum C 115 up to 50 ug/mL by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1102093Acaricidal activity against Dermatophagoides farinae assessed as mortality at 0.8 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID376050Antifungal activity against Saccharomyces cerevisiae ATCC 9763 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1501095Antileishmanial activity against Leishmania donovani MHOM/IN/AG/83 promastigotes after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1501098Cytotoxicity against BALB/c mouse peritoneal macrophages after 48 hrs by MTT assay2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID376049Antifungal activity against Candida albicans ATCC 10231 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID392785Inhibition of soybean 15-lipoxygenase2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors.
AID334993Antimicrobial activity against Streptococcus mutans ATCC 25175 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID252044Percent inhibition of nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages at 100 uM of compound2005Bioorganic & medicinal chemistry letters, Apr-01, Volume: 15, Issue:7
Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.
AID655420Transactivation of PPAR expressed in HepG2 cells after 20 hrs by luminescence assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1102087Acaricidal activity against Dermatophagoides pteronyssinus after 24 hr by fabric disk assay2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1104346Oviposition deterrent activity against adult female Trichoplusia ni (cabbage looper) moths introduced along with male moths into oviposition cage containing compound pretreated cabbage leaves assessed as eggs laying on the leaf disks at 0.25% after 48 hr2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID376051Antifungal activity against Cryptococcus neoformans ATCC 32264 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1102052Acaricidal activity against Dermatophagoides pteronyssinus assessed as mortality at 25.5 ug/cm2 applied as fumes in closed container after 24 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID334991Antimicrobial activity against Propionibacterium acnes ATCC 11827 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334995Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID337836Antifungal activity against Candida albicans ATCC 18804 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID376042Antifungal activity against Trichophyton mentagrophytes ATCC 9972 up to 50 ug/mL by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID1104345Toxicity against third-instar larval stage of Trichoplusia ni (cabbage looper) assessed as mortality at 0.25% after 24 hr by contact toxicity bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID248765Inhibitory concentration of compound on nitric oxide (NO) production in lipopolysaccharide activated mouse peritoneal macrophages2005Bioorganic & medicinal chemistry letters, Apr-01, Volume: 15, Issue:7
Structure-activity relationships of 1'S-1'-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages.
AID652615Cytotoxicity against human HepG2 cells by MTT assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1501096Antileishmanial activity against Leishmania donovani MHOM/IN/AG/83 amastigotes infected in BALB/c mouse peritoneal macrophages after 42 hrs by Giemsa staining-based microscopic analysis2017European journal of medicinal chemistry, Oct-20, Volume: 139Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
AID1102071Acaricidal activity against Dermatophagoides farinae assessed as mortality at 1.2 ug/cm2 after 48 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID334990Antimicrobial activity against Brevibacterium ammoniagenes ATCC 6872 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID334998Antimicrobial activity against Candida utilis ATCC 9226 after 2 days by twofold serial broth dilution method1992Journal of natural products, May, Volume: 55, Issue:5
Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial.
AID1102064Acaricidal activity against Dermatophagoides farinae assessed as mortality at 1.2 ug/cm2 after 72 hr by fabric disk assay relative to untreated control2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID376053Antifungal activity against Aspergillus fumigatus ATCC 26934 by agar dilution method1999Journal of natural products, Oct, Volume: 62, Issue:10
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
AID655422Transactivation of GAL4-fused PPARgamma LBD expressed in HepG2 cells after 20 hrs by luminescence assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID337835Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1102088Ratio of benzyl benzoate LD50 to compound LD50 for Dermatophagoides farinae2003Journal of agricultural and food chemistry, Feb-12, Volume: 51, Issue:4
Acaricidal activity of clove bud oil compounds against Dermatophagoides farinae and Dermatophagoides pteronyssinus (Acari: Pyroglyphidae).
AID1104347Feeding deterrent activity against freshly molted third-instar larval stage of Trichoplusia ni (cabbage looper) in compound pretreated cabbage leaves after 3 to 5 hr by leaf disk choice bioassay2010Journal of agricultural and food chemistry, Apr-28, Volume: 58, Issue:8
Dialkoxybenzene and dialkoxyallylbenzene feeding and oviposition deterrents against the cabbage looper, Trichoplusia ni: potential insect behavior control agents.
AID652614Transactivation of GAL4-fused PPARbeta LBD expressed in HepG2 cells after 20 hrs by luminescence assay2012Bioorganic & medicinal chemistry letters, Apr-01, Volume: 22, Issue:7
Anti-inflammatory and PPAR transactivational effects of secondary metabolites from the roots of Asarum sieboldii.
AID1802985Lipoxygenase Activity Assay from Article 10.3109/14756366.2010.495717: \\Synthesis and SAR comparative studies of 2-allyl-4-methoxy-1-alkoxybenzenes as 15-lipoxygenase inhibitors.\\2011Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 26, Issue:2
Synthesis and SAR comparative studies of 2-allyl-4-methoxy-1-alkoxybenzenes as 15-lipoxygenase inhibitors.
AID1801921Lipo-oxygenase Inhibitory Assay from Article 10.1111/cbdd.12779: \\2-Prenylated m-dimethoxybenzenes as potent inhibitors of 15-lipo-oxygenase: inhibitory mechanism and SAR studies.\\2016Chemical biology & drug design, 09, Volume: 88, Issue:3
2-Prenylated m-dimethoxybenzenes as potent inhibitors of 15-lipo-oxygenase: inhibitory mechanism and SAR studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (241)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (3.73)18.7374
1990's18 (7.47)18.2507
2000's65 (26.97)29.6817
2010's118 (48.96)24.3611
2020's31 (12.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.05 (24.57)
Research Supply Index5.51 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index83.62 (26.88)
Search Engine Supply Index2.99 (0.95)

This Compound (39.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.41%)5.53%
Reviews10 (4.10%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other233 (95.49%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]